Financial Performance - The company's operating revenue for Q1 2023 was ¥165,554,014.36, representing a decrease of 19.32% compared to the same period last year[5]. - The net profit attributable to shareholders was ¥21,841,167.37, down 32.97% year-on-year[5]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥15,996,875.98, a decline of 49.85% compared to the previous year[5]. - The net cash flow from operating activities was negative at -¥3,779,773.84, a decrease of 114.44% year-on-year[5]. - Basic earnings per share were ¥0.22, down 49.73% from the same period last year[5]. - Total operating revenue for Q1 2023 was RMB 165,554,014.36, a decrease of 19.3% compared to RMB 205,202,272.10 in Q1 2022[17]. - Net profit for Q1 2023 was CNY 21,841,167.37, down 33.2% from CNY 32,584,874.61 in Q1 2022[18]. - Total comprehensive income for Q1 2023 was CNY 21,800,466.16, down 33.4% from CNY 32,632,663.34 in Q1 2022[19]. - Basic and diluted earnings per share for Q1 2023 were both CNY 0.22, compared to CNY 0.45 in Q1 2022[19]. Assets and Liabilities - Total assets at the end of the reporting period were ¥2,158,890,370.33, a slight increase of 1.06% from the end of the previous year[6]. - Current assets as of March 31, 2023, totaled RMB 1,959,316,719.12, slightly down from RMB 1,982,905,869.72 at the end of 2022[13]. - Cash and cash equivalents increased to RMB 256,351,665.33 from RMB 213,932,379.63, reflecting a growth of 19.8%[13]. - Accounts receivable rose to RMB 232,523,530.55, up from RMB 206,343,293.94, indicating an increase of 12.7%[13]. - Total liabilities decreased to RMB 240,161,401.85 from RMB 246,975,135.79, a reduction of 2.8%[15]. - Total assets as of March 31, 2023, were RMB 2,158,890,370.33, compared to RMB 2,136,270,721.72 at the end of 2022, showing a slight increase of 1.1%[15]. - Non-current assets increased to RMB 199,573,651.21 from RMB 153,364,852.00, representing a significant growth of 30.1%[14]. Research and Development - R&D investment totaled ¥18,263,253.81, an increase of 34.93% year-on-year, accounting for 11.03% of operating revenue, up 4.44 percentage points[6]. - Research and development expenses increased to CNY 18,263,253.81, up 35.0% from CNY 13,535,566.74 in the previous year[18]. Market and Operational Insights - The company maintained stable demand for its main products, with sufficient orders on hand despite the decline in profits[8]. - The decrease in net profit was attributed to price reductions for mature products and increased R&D expenses, as new products have not yet contributed significantly to profits[8]. - The company is focusing on enhancing its product development and market expansion strategies in the upcoming quarters[12]. - There are no significant changes in the top ten shareholders' structure or any related party transactions reported during the period[12]. Operating Costs and Cash Flow - Total operating costs for Q1 2023 were CNY 153,202,755.59, a decrease of 6.6% compared to CNY 163,934,944.82 in Q1 2022[18]. - Cash flow from operating activities showed a net outflow of CNY 3,779,773.84, compared to a net inflow of CNY 26,175,808.70 in Q1 2022[22]. - Investment activities generated a net cash inflow of CNY 57,054,012.24, compared to a net outflow of CNY 5,904,114.22 in the previous year[22]. - Tax expenses for Q1 2023 were CNY 66,047.65, a significant decrease from CNY 5,213,550.41 in Q1 2022[18].
德科立(688205) - 2023 Q1 - 季度财报